First malaria drug in 60 years given approval:
A drug to treat malaria – the first such pill to get approval in sixty years – has been given the green light by authorities in the U.S.A.
The medicine is specifically for the recurring type of malaria, which makes 8.5 million individuals sick annually.
This type of malaria is a specific challenge to get rid of because it can remain dormant within the liver for years before reawakening many times.
Scientists have described tafenoquine as a “phenomenal achievement.”
Regulators around the world will currently consider the drug to see if they can recommend it for their populations.